SLC6A3 and attention deficit-hyperactivity disorder: Dysregulated palmitoylation of these proteins has been associated with diseases including schizophrenia, attention deficit hyperactivity disorder, and major depressive disorder [66, 67], supporting that similar impacts on DAT could contribute to imbalanced reuptake in DA disorders.